1,960
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Danhong injection represses diabetic retinopathy and nephropathy advancement in diabetic mice by upregulating microRNA-30d-5p and targeting JAK1

, , , , , , , & show all
Pages 8187-8200 | Received 05 Aug 2021, Accepted 12 Nov 2021, Published online: 31 Mar 2022

References

  • Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370(16):1514–1523.
  • Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.
  • Huang H, Zhang G, Ge Z. lncRNA MALAT1 promotes renal fibrosis in diabetic nephropathy by targeting the miR-2355-3p/IL6ST axis. Front Pharmacol. 2021;12:647650.
  • Li H, Fan J, Zhao Y, et al. Nuclear miR-320 mediates diabetes-induced cardiac dysfunction by activating transcription of fatty acid metabolic genes to cause lipotoxicity in the heart. Circ Res. 2019;125(12):1106–1120.
  • Liu BY, Li L, Bai LW, et al. Long non-coding RNA XIST attenuates diabetic peripheral neuropathy by inducing autophagy through microRNA-30d-5p/sirtuin1 axis. Front Mol Biosci. 2021;8:655157.
  • Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380(9854):1662–1673.
  • Sharma D, Bhattacharya P, Kalia K, et al. Diabetic nephropathy: new insights into established therapeutic paradigms and novel molecular targets. Diabetes Res Clin Pract. 2017;128:91–108.
  • Zhang L, Zhou Y, Zhou F, et al. Altered expression of long noncoding and messenger RNAs in diabetic nephropathy following treatment with rosiglitazone. Biomed Res Int. 2020;2020:1360843.
  • Wang ZS, Qiu T, Liu XH, et al. Tripterysium glycosides preconditioning attenuates renal ischemia/reperfusion injury in a rat model. Int Urol Nephrol. 2016;48(2):213–221.
  • Cai F, Jiang H, Li Y, et al. Upregulation of long non-coding RNA SNHG16 promotes diabetes-related RMEC dysfunction via activating NF-κB and PI3K/AKT pathways. Mol Ther Nucleic Acids. 2021;24:512–527.
  • Wan TT, Li XF, Sun YM, et al. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. Biomed Pharmacothe. 2015;74:145–147.
  • Hendrick AM, Gibson MV, Kulshreshtha A. Diabetic Retinopathy. Prim Care. 2015;42(3):451–464.
  • Zhang QQ, Dong X, Liu XG, et al. Rapid separation and identification of multiple constituents in Danhong injection by ultra-high performance liquid chromatography coupled to electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Chin J Nat Med. 2016;14(2):147–160.
  • Li SN, Li P, Liu WH, et al. Danhong injection enhances angiogenesis after myocardial infarction by activating MiR-126/ERK/VEGF pathway. Biomed Pharmacothe. 2019;120:109538.
  • Liu M, Pan Q, Chen Y, et al. Administration of Danhong injection to diabetic db/db mice inhibits the development of diabetic retinopathy and nephropathy. Sci Rep. 2015;5:11219.
  • Zeng M, Zhou H, He Y, et al. Danhong injection alleviates cerebral ischemia/reperfusion injury by improving intracellular energy metabolism coupling in the ischemic penumbra. Biomed Pharmacothe. 2021;140:111771.
  • Guo Y, Yang JH, Cao SD, et al. Effect of main ingredients of Danhong Injection against oxidative stress induced autophagy injury via miR-19a/SIRT1 pathway in endothelial cells. Phytomedicine. 2021;83:153480.
  • Jiang M, Wang H, Jin M, et al. Exosomes from MiR-30d-5p-ADSCs reverse acute ischemic stroke-induced, autophagy-mediated brain injury by promoting M2 microglial/macrophage polarization. Cell Physiol Biochem. 2018;47(2):864–878.
  • Zhao F, Qu Y, Zhu J, et al. miR-30d-5p plays an important role in autophagy and apoptosis in developing rat brains after hypoxic-ischemic injury. J Neuropathol Exp Neurol. 2017;76(8):709–719.
  • He M, Wang J, Yin Z, et al. MiR-320a induces diabetic nephropathy via inhibiting MafB. Aging (Albany NY). 2019;11(10):3055–3079.
  • Liu H, Wang X, Wang ZY, et al. Circ_0080425 inhibits cell proliferation and fibrosis in diabetic nephropathy via sponging miR-24-3p and targeting fibroblast growth factor 11. J Cell Physiol. 2020;235(5):4520–4529.
  • Wu L, Wang Q, Guo F, et al. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress. J Cell Physiol. 2021;236(2):1454–1468.
  • Xue L, Xiong C, Li J, et al. miR-200-3p suppresses cell proliferation and reduces apoptosis in diabetic retinopathy via blocking the TGF-β2/Smad pathway. Biosci Rep. 2020;40(11). DOI:10.1042/BSR20201545.
  • Yang Y, Zhou J, Li WH, et al. LncRNA NEAT1 regulated diabetic retinal epithelial-mesenchymal transition through regulating miR-204/SOX4 axis. PeerJ. 2021;9:e11817.
  • Huang Y, Yao P, Ke H, et al. Long noncoding RNA UCA1 promotes high glucose-induced human retinal endothelial cells angiogenesis via regulating miR4/VEGF〤. 2021.
  • Chen B, Li Y, Liu Y, et al. circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells. J Cell Physiol. 2019;234(11):21249–21259.
  • Hou Y, Zhang Y, Lin S, et al. Protective mechanism of apigenin in diabetic nephropathy is related to its regulation of miR-423-5P-USF2 axis. Am J Transl Res. 2021;13(4):2006–2020.
  • Zhang J, Chen M, Chen J, et al. Long non-coding RNA MIAT acts as a biomarker in diabetic retinopathy by absorbing miR-29b and regulating cell apoptosis. Biosci Rep. 2017;37(2).
  • Choby B. Diabetes update: prevention and management of diabetes complications. FP Essent. 2017;456:36–40.
  • Zhao YF, Wang ZQ, Yang J, et al. [Prevalence, awareness, status of treatment and control on type 2 diabetes mellitus among Chinese premenopausal women aged 18-49 in 2013]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(2):213–217.
  • Santovito D, Toto L, De Nardis V, et al. Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes. Sci Rep. 2021;11(1):4136.
  • Zhang J, Shi X, Gao J, et al. Danhong injection and trimetazidine protect cardiomyocytes and enhance calcium handling after myocardial infarction. Evid Based Complement Alternat Med. 2021;2021:2480465.
  • Wang L, Liu WX, Huang XG. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy. Exp Mol Pathol. 2020;116:104488.
  • Yang L, He K, Yao S, et al. Sevoflurane inhibits neuroblastoma cell proliferation and invasion and induces apoptosis by miR-144-3p/YAP1 axis. Basic Clin Pharmacol Toxicol. 2021;129(4):297–307.
  • Yang JJ, Zhao YH, Yin KW, et al. Dexmedetomidine inhibits inflammatory response and oxidative stress through regulating miR-205-5p by targeting HMGB1 in cerebral ischemic/reperfusion. Immunopharmacol Immunotoxicol. 2021;43(4):478–486.
  • Yin M, Chen WP, Yin XP, et al. LncRNA TUG1 demethylated by TET2 promotes NLRP3 expression, contributes to cerebral ischemia/reperfusion inflammatory injury. ASN neuro. 2021;13:17590914211003247.
  • Zhang M, Ge DJ, Su Z, et al. miR-137 alleviates focal cerebral ischemic injury in rats by regulating JAK1/STAT1 signaling pathway. Hum Exp Toxicol. 2020;39(6):816–827.
  • Smith P, Yao W, Shepard S, et al. Developing a JAK inhibitor for targeted local delivery: ruxolitinib cream. Pharmaceutics. 2021;13(7):1044 .